Previous chapter:
Chapter 1852 - 1294: Miraculous Power (Part 2)
Next chapter:
Chapter 1854 - 1294: Secret Operation (Part 2)
PREVIEW
... l, the FDA announced an emergency approval notice, allowing K Therapy to proceed with Phase II clinical trials in the United States, with conditions of strict safety monitoring and data collection. The important thing is that the door has opened.
Almost simultaneously, twelve major regulatory agencies, including the EMA, the UK Medicines Agency, the Japan Medicines Agency, and the Australia Medicines Agency, issued similar authorizations.
These decisions were driven not by pharma ...
YOU MAY ALSO LIKE





























